| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.4 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.051 | 0.4 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.4 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.042 | 0.4 |